ALBANY, New York, January 17, 2013 /PRNewswire/ --
According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Healthcare Contract Research Outsourcing Market (Contract Research Organizations, Clinical Data Management, Clinical Trial Laboratories, Regulatory Medical Writing, Academic Medical Center) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018", the global healthcare contract research outsourcing market was valued at USD 25.08 billion in 2011 and is forecasted to reach USD 65.03 billion by 2018, growing at a CAGR of 14.7% from 2012 to 2018.
Browse the full report at http://www.transparencymarketresearch.com/hcro-market.html
Global pharmaceutical and medical device industry is slowly transitioning from an integrated process model to outsourcing model, where pharmaceutical companies outsource various processes including clinical trials, medical writing, and regulatory processes to their contract research partners, who have relevant expertise. Major business segments outsourced include clinical trials and central lab services.
Contract research outsourcing market is propelled mainly by depleting product pipelines, patent expiries in the near future and declining productivity, especially in the last decade. Expertise available with contract research partners, reduced research process duration, cost savings, flexible pricing models and research globalization options are observed as major advantages for the pharmaceutical companies outsourcing their research processes to contract research units.
Related & Recently Published Reports by Transpa
|SOURCE Transparency Market Research|
Copyright©2012 PR Newswire.
All rights reserved